Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Journal of Thoracic Disease|March 30, 2018
Immunotherapy in surgically resectable non-small cell lung cancerDwight Owen, Jamie E Chaft
Annals of Translational Medicine|August 30, 2016
Have adjuvant tyrosine kinase inhibitors lost their shine?Joshua K Sabari, Jamie E Chaft
Translational Lung Cancer Research|March 10, 2023
Early-stage anaplastic lymphoma kinase (<i>ALK</i>)-positive lung cancer: a narrative reviewMonica F Chen, Jamie E Chaft
Lymphatic Research and Biology|December 31, 2004
Genetics of vascular anomalies: an updateJamie E Chaft, David A Steckman, Francine Blei
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 24, 2024
Moving Immunotherapy Into the Treatment of Resectable Non-Small Cell Lung CancerJamie E Chaft, Rafal Dziadziuszko, Bernardo Haddock Lobo Goulart
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Chemotherapy for lung cancers: here to stayMark G Kris, Matthew D Hellmann, Jamie E Chaft
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2022
Preoperative and Postoperative Systemic Therapy for Operable Non-Small-Cell Lung CancerJamie E Chaft, Yu Shyr, Boris Sepesi, et al.
Cancer Treatment Reviews|June 2, 2026
Treatments for human epidermal growth factor receptor 2 (HER2)-altered cancers evaluated using a tumor‑agnostic approach: A narrative reviewGuilherme Harada, Jamie E Chaft, Alison M Schram, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
Updates on the Perioperative Management of Resectable Non-Small Cell Lung CancerStacey M Frumm, Narjust Florez, Jay M Lee, et al.
The Annals of Thoracic Surgery|August 26, 2017
Initial Experience With Lung Cancer Resection After Treatment With T-Cell Checkpoint InhibitorsJamie E Chaft, Matthew D Hellmann, Moises J Velez, et al.
Pageof 14